Literature DB >> 523478

Sampling schemes and ascertainment.

E A Thompson, C Cannings.   

Abstract

Previous approaches to the ascertainment problem have been in terms of a registry-type situation in which the sampled structure is a random variable. However, with the exception of Bailey (1951), previous authors have conditioned on this structure. In extending the theory to pedigrees, a registry situation may also be considered, providing neither the structure nor any part of it (e.g., ages of individuals) are conditioned upon, but it may often be neither practicable nor relevant to do so. In many studies the sampling scheme may fix the number of pedigrees, analyzed, and classical "ascertainment probabilities" are no longer applicable. In an infinite population, in which the ascertainment of and phenotypic observations on, affect neither the distribution of other ascertainments or phenotypic distributions on other pedigrees and chance multiple ascertainments cannot occur, ascertainment corrections are relatively straightforward. However, effective population sizes with regard to particular rare traits may often be small, and the problem of ascertainment corrections in this case has not been fully analyzed, although some preliminary results are presented.

Mesh:

Year:  1979        PMID: 523478

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  3 in total

1.  The essence of single ascertainment.

Authors:  S E Hodge; V J Vieland
Journal:  Genetics       Date:  1996-11       Impact factor: 4.562

2.  Aspects of parameter estimation in ascertainment sampling schemes.

Authors:  W J Ewens
Journal:  Am J Hum Genet       Date:  1982-11       Impact factor: 11.025

3.  Genetic investigation of quantitative traits related to autism: use of multivariate polygenic models with ascertainment adjustment.

Authors:  Yun Ju Sung; Geraldine Dawson; Jeffrey Munson; Annette Estes; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Am J Hum Genet       Date:  2004-11-16       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.